Skip to main content
. 2016 Jul 7;13:48. doi: 10.1186/s12977-016-0279-4

Table 2.

N332-directed heterologous NAb responses in elite neutralizer D16916

ID50 a Foldd reduction
WTb N332A
92BR020 1711 49 35
JRCSF 211 60 3.5
MGRM-C-026 269 70 3.9
T332Nc WT (T332)
BG505 63 <40 >1.5

a50 % inhibitory dilution (ID50)

bID50 of month 14 serum tested against the 92BR020 and JRCSF (both clade B) and MGRM-C-026 (clade C) viruses and their N332A mutants

cID50 of month 30 serum tested against the BG505 virus (clade A) and its T332N mutant

dThe fold-reduction in neutralization as a consequence of the lack of the N332-glycan